Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Pipeline fills as foreign and domestic names prepare to print -
Danish firm specialised in treatment for metabolic diseases issues 6.5m shares
-
UK pharma latest high rated company to hit the euro market this week
-
Rise of mRNA technology was a gamechanger for the sector, says analyst
-
Vaccine maker issued shares in oversubscribed deal to fund acquisition
-
